#None #Brazil #Rejuran #PharmaResearch #DermaDream

PharmaResearch Expands to Brazil with Strategic Agreement

In a significant move to tap into the flourishing aesthetic market of Brazil, PharmaResearch Co., Ltd., under the leadership of CEO Jihoon Sohn, has announced its exclusive supply agreement for Rejuran with local partner DermaDream. This agreement was formalized in January during the esteemed IMCAS World 2026 congress, held in the picturesque city of Paris, France.

Brazil holds the distinction of being the largest aesthetic market in Latin America. The country has witnessed a steady increase in the demand for aesthetic procedures and skin regeneration products, which makes it a strategically important target for PharmaResearch. Through this exclusive deal, the company aims to navigate the Brazilian market's complexities and align its products with local customer needs and regulatory standards.

DermaDream, a reputed name in Brazil's aesthetic landscape, will take on the role of PharmaResearch's exclusive distributor for Rejuran. Known for its robust experience in product marketing and distribution, DermaDream boasts an established sales network and a solid understanding of the regulatory challenges in the region. This partnership is anticipated to create a strong institutional and commercial foundation for PharmaResearch's ambitious venture into Brazil.

PharmaResearch aims to adopt a measured and phased approach to its market entry strategy in Brazil, ensuring it adheres to local regulations while building a brand presence. A representative from PharmaResearch stated, "Brazil is a core market in the Latin American aesthetic industry, and this agreement serves as a pivotal development in our global expansion strategy. We are committed to a methodical business development that thoughtfully aligns with the market's unique needs."

Expanding further, PharmaResearch's collaboration efforts are not limited to Brazil. In 2025, the company entered into a partnership with Laboratoires VIVACY, a French aesthetic firm, to strengthen its foothold across 22 countries in Europe, including major destinations like the United Kingdom, Germany, France, Italy, and Spain. This aligns with PharmaResearch’s vision of becoming a globally influential leader in the biopharmaceutical sector.

At the heart of PharmaResearch's innovations is its focus on regenerative medicine, dedicated to improving global health outcomes through advanced products. The company boasts a diverse portfolio, which includes not only pharmaceuticals but also cosmetics, medical devices, and dietary supplements underpinned by patented core ingredients such as DOT™ PDRN and DOT™ PN.

Headquartered in Gangneung-si, Gangwon-do, South Korea, and with a subsidiary in Costa Mesa, California, PharmaResearch continues to drive innovation and expand its global influence in the biopharmaceutical industry. As it prepares to make a significant impact in Brazil's aesthetic market with Rejuran, the company reflects on its expansion goals while bearing in mind the complexities and regulatory expectations prevalent in the Latin American regions.

For more insights about their ventures, you can visit PharmaResearch's official website.